Cancer patients who do research get newest drugs

USA Today

Patients who sought information from the Internet, newspapers and magazines were more likely than others to have heard of the "targeted" therapies cetuximab, sold as Erbitux, and bevacizumab, sold as Avastin. But those who pursued second opinions from doctors as part of their research were the most likely actually to be prescribed these drugs, says the study led by the Dana-Farber Cancer Institute in Boston and published online today in Cancer ... Read More